Director Jan De Witte filed a Form 4 with the SEC on November 20, 2026, disclosing the acquisition of 1,109 ResMed Inc. restricted stock units on November 19, 2026, at no cost.

Key Highlights

  • Reporting person: Jan De Witte, a director of ResMed Inc. (NYSE:RMD)
  • Transaction date: November 19, 2026
  • Securities acquired: 1,109 shares of ResMed Common Stock in the form of Restricted Stock Units, acquired at $0
  • Post-transaction ownership: 4,881 shares of ResMed Common Stock held directly following the reported transaction
  • Vesting schedule: RSUs vest in full on the earlier of November 11, 2027, or the annual meeting of stockholders in the year following the grant date

ResMed Director Jan De Witte Awarded RSUs at No Cost in November 2026

According to the Form 4 filed with the SEC on November 20, 2026, Jan De Witte, a director of ResMed Inc. (NYSE:RMD), reported the acquisition of 1,109 shares of ResMed Common Stock in the form of Restricted Stock Units (RSUs). The transaction was dated November 19, 2026, and the filing records the acquisition price as $0, indicating the RSUs were awarded rather than purchased.

The filing discloses that following the reported transaction, De Witte directly holds 4,881 shares of ResMed Common Stock. The RSUs are described in the filing's footnote as shares that "vest in full on the earlier of 11/11/2027, or the annual meeting of stockholders in the year following the grant date." No derivative securities were reported in Table II of the filing.

The Form 4 was signed by Jan De Witte in his capacity as director and filed on November 20, 2026. The filing identifies the transaction code as "A," denoting an acquisition. The form does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as that checkbox is not checked.

What Was Disclosed

ResMed director Jan De Witte reported acquiring 1,109 RSUs on November 19, 2026, at no cost, bringing his direct beneficial ownership of ResMed Common Stock to 4,881 shares. The RSUs vest no later than November 11, 2027.